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Abstract
Background: Leishmania infantum is a flagellated protozoan parasite that is able to parasitize blood and tissue.
Leishmania species cause a spectrum of clinical disease with cutaneous, visceral or mucosal involvement. L. infantum is
recognised as a cause of visceral leishmaniasis (VL) and is less commonly reported as a cause of cutaneous leishmaniasis
(CL) from countries around the Mediterranean basin. This is the first report of imported L. infantum CL to Australia
and is remarkable for a 19 year period between the patient’s exposure to an endemic region, and the manifestation
of symptoms.
Case presentation: A 76 year old Italian-born man presented to our institution with a non-healing lesion over his
upper lip, abutting his nasal mucosa. The patient had travelled to Italy, an endemic area for L. infantum 19 years
earlier but had resided in Australia, a non-endemic area since. Histopathology performed on a biopsy of the
lesion demonstrated findings consistent with CL. A species specific polymerase chain reaction (PCR) performed
on the tissue detected L. infantum. The patient had complete clinical recovery following treatment with Liposomal
amphotericin B at a dose of 3 mg/kg for five days followed by a subsequent 3 mg/kg dose at day ten.
Conclusions: L. infantum should be recognised as a cause of imported CL in returned travellers from the Mediterranean.
In this case, the incubation period for L. infantum CL was at least 19 years. This case adds to the described spectrum of
clinical presentations of leishmaniasis and supports the theory of parasite persistence underlying natural immunity and
recurrence of disease. Clinicians should consider L. infantum CL in the differential diagnosis of a non-healing skin
lesion in any patient who reports travel to the Mediterranean, even when travel occurred several years before
clinical presentation.
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Background
Leishmania species are flagellated protozoa that parasitize
the blood or tissue. Infection is transmitted to humans by
the bite of a female Phlebotomus sand fly. The classical
form of visceral disease, “kala-azar”, is characterized by
fever, anaemia and splenomegaly. Leishmaniasis is recog-
nized by the world health organization (WHO) as a
neglected tropical disease [1]. It causes significant morbid-
ity and mortality worldwide with an estimated 12 million
people infected in over 88 countries [1]. L. infantum is
well recognized as the etiological agent of VL in southern
Europe, the Middle East and North Africa [2]. CL due to
L. infantum has only more recently been recognized. Del
Giudice et al, described L. infantum as a cause of CL in 3
patients and 3 adults from southern France in 1998 [3].
More recently cases from Portugal and Malta have been
described [4,5]. Herein we describe the first case of
imported L. infantum CL into Australia. This case is made
even more remarkable by the 19 year period between our
patient traveling to an endemic region and presenting with
disease. The implication this has for our understanding of
the disease pathogenesis and immunity are discussed.* Correspondence: amy.crowe@svha.org.au
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Case presentation
A 76 year-old man was referred to our hospital with a
10 month history of an enlarging plaque on the cutaneous
aspect of the upper lip. He had presented six months pre-
viously with symptoms of nasal stuffiness and epistaxis.
The lesion began as a small nodule.
Past medical history included type-2 diabetes mellitus,
ischaemic heart disease and hypertension. The man was
born in Italy. In 1952 he immigrated to Australia. He
resided in the Northern Territory for seven years then
had resided in the outer suburbs of Melbourne, Victoria,
since. 19 years prior to presentation he had travelled
back to Italy and southern France. He denied any other
travel. The man could not recall any similar facial lesions
in the past.
Examination revealed a 2 × 1.7 cm plaque involving the
cutaneous aspect of the upper lip bordering the nostrils
(Figure 1a). The lesion had a moderate exudate and some
scaling. The patient was afebrile with no splenomegaly.
Two 2 mm × 4 mm biopsies of the lesion were taken.
Histopathology (Figure 2) revealed mixed suppurative
and granulomatous inflammation in the dermis with
prominent plasma cells. Innumerable dot-shaped micro-
organisms of approximately 3 microns in diameter were
seen filling histiocytes. Giemsa stain of these microor-
ganisms was positive, morphologically consistent with
amastigotes of Leishmania species. Periodic acid Schiff
and Grocott (silver) stains for fungi were negative.
The identification and speciation of L. infantum was
confirmed by two molecular methods. Polymerase chain
reaction (PCR) targeting of the internal transcribed spacer
(ITS) region and subsequent digestion of the amplicon
with the restriction enzyme HaeIII was performed as pre-
viously described [6]. The restriction fragment length
polymorphism (RFLP) banding pattern was consistent
with L. donovani complex. In order to confirm genotyping
results and to further speciate, the sample was analyzed
by another PCR-RFLP genotyping method targeting the
miniexon gene according to the genotyping scheme
described elsewhere [7]. The banding pattern was con-
sistent with L. infantum.
Standard bacterial cultures revealed no growth at
48 hours. A human immunodeficiency virus (HIV) anti-
body test was negative. Baseline renal function was
within normal range. A peripheral lymphocyte count
demonstrated a slight decrease in CD4 T- cells (0.48 ×
109/L), this persisted post treatment and no cause for
this was identified.
Due to the anticipated pain of intra-lesional injections,
infection with a species that causes visceral disease and
concern regarding mucosal involvement, the patient was
given intravenous liposomal amphotericin B (3 mg/kg)
daily for five days with a further infusion at day ten.
Review a month later showed minor improvement in the
size of the lesion with persistent cracking and erythema.
Suspecting secondary bacterial infection a course of anti-
biotics (Cephalexin) was prescribed. A second biopsy was
performed three months post treatment. This revealed
marked granulomatous and inflammatory reactions with
occasional amastigotes. A further dose of liposomal am-
photericin B at 3 mg/kg was given. Topical hydrocortisone
was prescribed to manage surrounding inflammation. On
review eight months after treatment, there was complete
resolution of the lesion (Figure 1b).
Conclusions
Leishmaniasis is distinguished by both clinical presenta-
tion and geographic origin. VL is predominantly caused
by L. donovani complex, consisting of L. donovani and
L. infantum [2]. CL is predominantly caused by L. major,
L. tropica, L. donovani and L. aethiopica in the old world
(Middle East, Pakistan, Africa) and by L. mexicana, L.
amazonensis and L. braziliensis in the new world (Central
and South America, Amazon basin) [2].
Post kala-azar dermal leishmaniasis, diffuse cutaneous
leishmaniasis and leishmania recividans are included in
the clinical spectrum of leishmaniasis [2]. Post kala-azar
dermal leishmaniasis follows VL and is most commonly
caused by L. donovani [2]. Diffuse cutaneous leishmaniasis
is more commonly described in new world CL. Leishman-
iasis recividans is an uncommon presentation of CL, almost
exclusively caused by L. tropica [8-10] and characterized by
Figure 1 Upper lip lesion (A) Appearance of lesion prior to treatment (B) Resolution of lesion 8 months post treatment.
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a relapsing course and a paucity of amastigotes on histo-
pathological examination of skin lesions [10]. Periods of up
to 43 years between episodes of leishmaniasis recividans
have been described [8].
L. infantum VL in the Mediterranean is a well de-
scribed zoonosis with various Phlebotomus species of
sand-fly acting as the vector and dogs serving as the
primary reservoir [11,12]. L. infantum causing limited
cutaneous leishmaniasis (LCL) has been described in
adults and children from southern France, Italy, Portugal
and Malta [3-5]. L. infantum LCL mainly occurs in ex-
posed areas and usually has a nodular appearance, al-
though infiltrative lesions have also described [3-5].
Our patient did not present with symptoms until
19 years after travel to an endemic country. Previously
reported cases of CL imported into Australia report on-
set of symptoms within months of travel to, or residence
in an endemic country [13-15].
This case report describes a very uncommon case of
L. infantum LCL with a very long incubation period.
Reactivation of parasites in this case is likely to have
occurred in the setting of declining immune function,
caused by advancing age and CD4 lymphopenia. Pro-
longed incubation periods with old world CL have previ-
ously been described [16] and and low CD4 cell subsets
have been recognized as a risk factor for recurrence in
HIV-1 and L. infantum co-infection [17,18]. Asymptom-
atic L. infantum parasitaemia has been documented in
HIV-1 co-infected patients in endemic areas [19]. It is less
likely this case represents a case of Leishmania recividans,
as our patient has several inconsistent features; no history
of preceding episodes, abundant amastigotes present on
the histopathology and infection with a Leishmania
species that has never been described to cause leishmania
recividans.
A recent review of 213 cases in returned travelers
identified 20 cases of old-world CL caused by L. donovani
complex, which encompasses L. infantum [20]. 71% were
tourists from the Mediterranean. In a series of cases
imported into Australia, two were identified (by PCR) to
be caused by L. infantum. One case presented as VL, the
other presented with post-kala-azar dermal leishmaniasis.
Both patients had a history of travel to Greece [21].
More recent and therefore local acquisition in our pa-
tient is unlikely. No locally acquired case of leishmaniasis
in humans has ever been reported in Australia. A novel
species of leishmaniasis causing CL has been described
in Australian macropods (Kangaroos and Wallaroos)
[22] but this species is phylogenetically distinct from L.
infantum (the species identified by PCR in our case).
Phlebotomus species of sandflies have been identified
from various Australian regions (mainly Queensland)
[23], so vector transmission via an imported reservoir
(e.g.- infected imported dogs) is a theoretical possibility,
however our patient did not report any contact with
imported dogs.
Diagnosing CL in non-endemic areas is difficult and
often delayed. Tissue histopathology is crucial for diag-
nosis. On hematoxylin and eosin stain, amastigote stages
(intracellular form) can be seen within macrophages in
the dermal layer. The cytoplasm of the amastogotes stains
light blue, whilst the nucleus and kinetoplast (bar-shaped
Figure 2 Upper lip punch biopsy. H&E stain (x40 magnification) demonstrating innumerable dot-shaped microorganisms suggestive of
amastigote of Leishmania species.
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mitochondrial structure) stain red with Giemsa stain.
Amastigotes within tissue specimens can be differentiated
from fungal organisms because they do not stain positive
with periodic acid-Schiff, mucicarmine, or silver stain [24].
Leishmania promastigotes (extracellular form) may be
demonstrated from culture. Selective media such as
Novy, MacNeal and Nicolle’s medium are required for
growth. Promastigote stages can be seen on a wet mount
from media growth and stain with Giemsa [24].
Leishmaniasis serology and antigen based skin tests are
problematic in non-endemic areas and are not available in
Australia. Leishmaniasis PCR on tissue is sensitive and
specific and allows species differentiation [6,7,21].
Evidence on the best management of CL caused by
L .infantum is lacking [25]. Successful treatment with
both pentavalent antimony and amphotericin has been
described. We used liposomal amphotericin B with good
results due to the concern about mucosal involvement
and infection with a species more commonly implicated
in VL.
In summary we present an unusual case of L. infantum
CL in a 76 year old Italian man with mild CD4 lymphope-
nia and a history of travel to an endemic area 19 years
preceding presentation. This case demonstrates that CL
caused by L. infantum may have a long incubation period.
L. infantum should be recognized as a cause of imported
CL in patients who have travelled to the Mediterranean.
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